MRK Merck & Co Inc

Price (delayed)

$110.85

Market cap

$281.05B

P/E Ratio

18.38

Dividend/share

$2.76

EPS

$6.03

Enterprise value

$300.32B

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the ...

Highlights
The gross profit has grown by 33% year-on-year and by 3.3% since the previous quarter
The revenue has grown by 28% YoY and by 3.2% from the previous quarter
The net income has surged by 112% year-on-year but it has declined by 8% since the previous quarter
The EPS has soared by 112% YoY but it has contracted by 8% from the previous quarter

Key stats

What are the main financial stats of MRK
Market
Shares outstanding
2.54B
Market cap
$281.05B
Enterprise value
$300.32B
Valuations
Price to earnings (P/E)
18.38
Price to book (P/B)
6.32
Price to sales (P/S)
4.76
EV/EBIT
17.91
EV/EBITDA
14.57
EV/Sales
5.09
Earnings
Revenue
$58.97B
EBIT
$16.77B
EBITDA
$20.62B
Free cash flow
$15.25B
Per share
EPS
$6.03
Free cash flow per share
$6.02
Book value per share
$17.55
Revenue per share
$23.28
TBVPS
$25.48
Balance sheet
Total assets
$107.08B
Total liabilities
$62.56B
Debt
$30.42B
Equity
$44.46B
Working capital
$10.56B
Liquidity
Debt to equity
0.68
Current ratio
1.46
Quick ratio
0.9
Net debt/EBITDA
0.93
Margins
EBITDA margin
35%
Gross margin
70.5%
Net margin
25.9%
Operating margin
30.7%
Efficiency
Return on assets
14.3%
Return on equity
36.6%
Return on invested capital
26.9%
Return on capital employed
19.9%
Return on sales
28.4%
Dividend
Dividend yield
2.49%
DPS
$2.76
Payout ratio
45.8%

MRK stock price

How has the Merck stock price performed over time
Intraday
0.69%
1 week
0.96%
1 month
9.21%
1 year
51.41%
YTD
44.64%
QTD
28.72%

Financial performance

How have Merck's revenue and profit performed over time
Revenue
$58.97B
Gross profit
$41.57B
Operating income
$18.08B
Net income
$15.26B
Gross margin
70.5%
Net margin
25.9%
Merck's operating income has soared by 193% YoY but it has decreased by 4.3% from the previous quarter
Merck's operating margin has surged by 129% YoY but it has decreased by 7% QoQ
The net income has surged by 112% year-on-year but it has declined by 8% since the previous quarter
MRK's net margin has surged by 66% year-on-year but it is down by 11% since the previous quarter

Growth

What is Merck's growth rate over time

Valuation

What is Merck stock price valuation
P/E
18.38
P/B
6.32
P/S
4.76
EV/EBIT
17.91
EV/EBITDA
14.57
EV/Sales
5.09
The EPS has soared by 112% YoY but it has contracted by 8% from the previous quarter
The P/E is 47% lower than the 5-year quarterly average of 34.7 but 27% higher than the last 4 quarters average of 14.4
Merck's equity has increased by 24% YoY and by 2.8% from the previous quarter
The price to book (P/B) is 23% higher than the last 4 quarters average of 5.1 but 2% lower than the 5-year quarterly average of 6.4
The revenue has grown by 28% YoY and by 3.2% from the previous quarter
MRK's P/S is 21% above its last 4 quarters average of 3.9 and 5% above its 5-year quarterly average of 4.5

Efficiency

How efficient is Merck business performance
The company's return on assets has surged by 81% YoY but it fell by 11% QoQ
The ROIC has soared by 68% YoY but it fell by 12% QoQ
Merck's ROE has soared by 54% YoY but it has decreased by 13% from the previous quarter
The ROS has soared by 50% YoY but it has contracted by 12% from the previous quarter

Dividends

What is MRK's dividend history
DPS
$2.76
Dividend yield
2.49%
Payout ratio
45.8%
Recent dividends

Financial health

How did Merck financials performed over time
The total assets is 71% more than the total liabilities
MRK's quick ratio is up by 15% year-on-year and by 6% since the previous quarter
The total assets has grown by 15% YoY
MRK's debt is 32% smaller than its equity
Merck's equity has increased by 24% YoY and by 2.8% from the previous quarter
MRK's debt is up by 15% year-on-year but it is down by 3.9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.